GGrantIndex
← Leaderboards

Patricia A. Ganz

Ohio State University

$11,268,092
Attributed
$16,409,650
Total exposure
22
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,719,649 · 20
CDC$690,001 · 1
AHRQ$0 · 1

By mechanism

R01$10,692,541 · 6
U01$3,725,399 · 1
P30$1,255,481 · 4
U58$690,001 · 1
M01$46,228 · 9
P01$0 · 1

Top collaborators

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms

Research focus

Malignant NeoplasmsResearch PersonnelBaseProgramsFundingMorbidity - Disease RateRandomizedSymptomsCancer PatientCancer TherapyCancer SurvivorSurvivorsAftercareOncologyBehavioralClinical ResearchPsychologicCollaborationsInstitutionReportingDesignBreast Cancer SurvivorCancer DiagnosisFatigue

Grant awards (53)

Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings$582,216
R01 · FY2025 · CA
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial$534,903
R01 · FY2025 · CA
Cancer Control and Survivorship (CCS)$116,678
P30 · FY2025 · CA · contact PI
Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings$515,404
R01 · FY2024 · CA
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial$507,667
R01 · FY2024 · CA
Cancer Control and Survivorship$155,272
P30 · FY2024 · CA · contact PI
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial$639,125
R01 · FY2023 · CA
Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials$350,000
U01 · FY2023 · CA
Cancer Control and Survivorship$155,277
P30 · FY2023 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$650,261
U01 · FY2022 · CA
Cancer Control and Survivorship$155,277
P30 · FY2022 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$666,397
U01 · FY2021 · CA
Cancer Control and Survivorship$155,277
P30 · FY2021 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$666,397
U01 · FY2020 · CA
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors$643,972
R01 · FY2020 · CA · contact PI
Cancer Control and Survivorship$86,998
P30 · FY2020 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$659,371
U01 · FY2019 · CA
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors$626,208
R01 · FY2019 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$732,973
U01 · FY2018 · CA
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors$639,777
R01 · FY2018 · CA · contact PI
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors$639,856
R01 · FY2017 · CA · contact PI
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors$668,024
R01 · FY2016 · CA · contact PI
ENHANCING OUTCOMES IN YOUNG BREAST CANCER SURVIVORS: A PROGRAM OF THE UCLA-LIVEST$230,000
U58 · FY2013 · DP · contact PI
Patients and Survivors$140,546
P30 · FY2013 · CA · contact PI
ENHANCING OUTCOMES IN YOUNG BREAST CANCER SURVIVORS: A PROGRAM OF THE UCLA-LIVEST$230,001
U58 · FY2012 · DP · contact PI
Patients and Survivors$99,702
P30 · FY2012 · CA · contact PI
ENHANCING OUTCOMES IN YOUNG BREAST CANCER SURVIVORS: A PROGRAM OF THE UCLA-LIVEST$230,000
U58 · FY2011 · DP · contact PI
Patients and Survivors$54,702
P30 · FY2011 · CA · contact PI
Cognitive Functioning After Breast Cancer Treatment$438,696
R01 · FY2010 · CA · contact PI
Patients and Survivors$69,662
P30 · FY2010 · CA · contact PI
THE UCLA FAMILIAL CANCER REGISTRY AND GENETIC EVALUATION PROGRAM$5,274
M01 · FY2010 · RR · contact PI
VITAMIN D IN BREAST CANCER: A CROSS-SECTIONAL OBSERVATIONAL STUDY IN RECENTLY DI$4,614
M01 · FY2010 · RR · contact PI
Cognitive Functioning After Breast Cancer Treatment$470,166
R01 · FY2009 · CA · contact PI
Patients and Survivors$66,090
P30 · FY2009 · CA · contact PI
THE UCLA FAMILIAL CANCER REGISTRY AND GENETIC EVALUATION PROGRAM$862
M01 · FY2009 · RR · contact PI
Cognitive Functioning After Breast Cancer Treatment$464,969
R01 · FY2008 · CA · contact PI
DOES BLOCKING PROINFLAMMATORY CYTOKINES DIMINISH CANCER-RELATED FATIGUE?$1,426
M01 · FY2008 · RR · contact PI
Cognitive Functioning After Breast Cancer Treatment$440,850
R01 · FY2007 · CA · contact PI
DOES BLOCKING PROINFLAMMATORY CYTOKINES DIMINISH CANCER-RELATED FATIGUE?$6,182
M01 · FY2007 · RR · contact PI
Cognitive Functioning After Breast Cancer Treatment$369,342
R01 · FY2006 · CA · contact PI
DOES BLOCKING PROINFLAMMATORY CYTOKINES DIMINISH CANCER-RELATED FATIGUE?$1,601
M01 · FY2006 · RR · contact PI
THE BIOPSYCHOSOCIAL MECHANISMS OF FATIGUE IN BREAST CANCER SURVIVORS$11,261
M01 · FY2005 · RR
Biopsychosocial Mechanisms of Fatigue in Breast Canc$14,189
M01 · FY2004 · RR
Endocrine /Immune Responses to Stress in Breast Cancer S$819
M01 · FY2004 · RR
BREAST CANCER--PREPARING FOR SURVIVORSHIP$331,241
R01 · FY2002 · CA
Missed opportunities for early detection &treatment for colorectal cancer$0
P01 · FY2002 · HS
IMPROVING COLORECTAL CANCER SCREENING RATES$593,284
R01 · FY2001 · CA
BREAST CANCER--PREPARING FOR SURVIVORSHIP$571,791
R01 · FY2001 · CA
Missed opportunities for early detection &treatment for colorectal cancer$0
P01 · FY2001 · HS
INTRADUCTAL BREAST PATHOLOGY IN HIGH RISK WOMEN$0
M01 · FY2001 · RR
BREAST CANCER--PREPARING FOR SURVIVORSHIP$564,923
R01 · FY2000 · CA
IMPROVING COLORECTAL CANCER SCREENING RATES$450,127
R01 · FY2000 · CA
Missed opportunities for early detection &treatment for colorectal cancer$0
P01 · FY2000 · HS